BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24183739)

  • 1. Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine mPGES-1.
    Hanke T; Rörsch F; Thieme TM; Ferreiros N; Schneider G; Geisslinger G; Proschak E; Grösch S; Schubert-Zsilavecz M
    Bioorg Med Chem; 2013 Dec; 21(24):7874-83. PubMed ID: 24183739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-based discovery of novel and selective mPGES-1 inhibitors Part 1: identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid.
    Lee K; Pham VC; Choi MJ; Kim KJ; Lee KT; Han SG; Yu YG; Lee JY
    Bioorg Med Chem Lett; 2013 Jan; 23(1):75-80. PubMed ID: 23218602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel mPGES-1 inhibitors through screening of a chemical library.
    Park SJ; Han SG; Ahsan HM; Lee K; Lee JY; Shin JS; Lee KT; Kang NS; Yu YG
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7335-9. PubMed ID: 23147075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new γ-hydroxybutenolides that preferentially inhibit the activity of mPGES-1.
    De Simone R; Bruno I; Riccio R; Stadler K; Bauer J; Schaible AM; Laufer S; Werz O
    Bioorg Med Chem; 2012 Aug; 20(16):5012-6. PubMed ID: 22795900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylpyrrolizines as inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX).
    Liedtke AJ; Keck PR; Lehmann F; Koeberle A; Werz O; Laufer SA
    J Med Chem; 2009 Aug; 52(15):4968-72. PubMed ID: 19719242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1).
    Rörsch F; Buscató E; Deckmann K; Schneider G; Schubert-Zsilavecz M; Geisslinger G; Proschak E; Grösch S
    J Med Chem; 2012 Apr; 55(8):3792-803. PubMed ID: 22449023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel myrtucommulones and structural analogues that target mPGES-1 and 5-lipoxygenase.
    Wiechmann K; Müller H; Huch V; Hartmann D; Werz O; Jauch J
    Eur J Med Chem; 2015 Aug; 101():133-49. PubMed ID: 26123643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of highly potent microsomal prostaglandin e2 synthase 1 inhibitors using the active conformation structural model and virtual screen.
    He S; Li C; Liu Y; Lai L
    J Med Chem; 2013 Apr; 56(8):3296-309. PubMed ID: 23527738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine mPGES-1 3D structure elucidation and inhibitors binding mode predictions by homology modeling and site-directed mutagenesis.
    Corso G; Coletta I; Ombrato R
    J Chem Inf Model; 2013 Jul; 53(7):1804-17. PubMed ID: 23789712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
    Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: use of a conformation-based hypothesis to facilitate compound design.
    Walker DP; Arhancet GB; Lu HF; Heasley SE; Metz S; Kablaoui NM; Franco FM; Hanau CE; Scholten JA; Springer JR; Fobian YM; Carter JS; Xing L; Yang S; Shaffer AF; Jerome GM; Baratta MT; Moore WM; Vazquez ML
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1120-6. PubMed ID: 23298810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).
    Lauro G; Strocchia M; Terracciano S; Bruno I; Fischer K; Pergola C; Werz O; Riccio R; Bifulco G
    Eur J Med Chem; 2014 Jun; 80():407-15. PubMed ID: 24794772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOX.
    Elkady M; Nieß R; Schaible AM; Bauer J; Luderer S; Ambrosi G; Werz O; Laufer SA
    J Med Chem; 2012 Oct; 55(20):8958-62. PubMed ID: 22992107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and competitive binding study discovered different binding modes of microsomal prostaglandin E synthase-1 inhibitors.
    He S; Lai L
    J Chem Inf Model; 2011 Dec; 51(12):3254-61. PubMed ID: 22077876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation.
    Arhancet GB; Walker DP; Metz S; Fobian YM; Heasley SE; Carter JS; Springer JR; Jones DE; Hayes MJ; Shaffer AF; Jerome GM; Baratta MT; Zweifel B; Moore WM; Masferrer JL; Vazquez ML
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1114-9. PubMed ID: 23260349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multi-step Virtual Screening Protocol for the Identification of Novel Non-acidic Microsomal Prostaglandin E
    Shekfeh S; Çalışkan B; Fischer K; Yalçın T; Garscha U; Werz O; Banoglu E
    ChemMedChem; 2019 Jan; 14(2):273-281. PubMed ID: 30537167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of N-amido-phenylsulfonamide derivatives as novel microsomal prostaglandin E
    Kim M; Kim G; Kang M; Ko D; Nam Y; Moon CS; Kang HM; Shin JS; Werz O; Lee KT; Lee JY
    Bioorg Med Chem Lett; 2021 Jun; 41():127992. PubMed ID: 33775835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel microsomal prostaglandin E
    Lauro G; Manfra M; Pedatella S; Fischer K; Cantone V; Terracciano S; Bertamino A; Ostacolo C; Gomez-Monterrey I; De Nisco M; Riccio R; Novellino E; Werz O; Campiglia P; Bifulco G
    Eur J Med Chem; 2017 Jan; 125():278-287. PubMed ID: 27688183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of 2-aryl substituted quinazolin-4(3H)-one, pyrido[4,3-d]pyrimidin-4(3H)-one and pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as microsomal prostaglandin E(2) synthase-1 inhibitors.
    Banerjee A; Pawar MY; Patil S; Yadav PS; Kadam PA; Kattige VG; Deshpande DS; Pednekar PV; Pisat MK; Gharat LA
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4838-44. PubMed ID: 25260492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.